NTRA 外国為替ニュース
Natera Announces Positive Results From IMvigor011 Phase III Study In Muscle-Invasive Bladder Cancer
Cell-free DNA testing company Natera, Inc. (NTRA) announced Friday an analysis from the IMvigor011 study that was presented at the European Association of Urology (EAU) Congress 2024 in Paris, France.
RTTNews
|
912日前
